Sequence information
Variant position: 854 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 911 The length of the canonical sequence.
Location on the sequence:
HLFTGIQIICLAVLWVVKST
P ASLALPFVLILTVPLRRVLL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human HLFTGIQIICLAVLWVVKSTP ASLALPFVLILTVPLRRVLL
Mouse HLFTGIQIICLAVLWVVKSTP ASLALPFVLILTVPLRRLIL
Rat HLFTGIQIICLAVLWVVKSTP ASLALPFVLILTVPLRRLLL
Chicken TSSPLTQILVVALLWGVKVSP ASLRCPFVLVLTVPLRRLLL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 911
Band 3 anion transport protein
Intramembrane
839 – 869
Discontinuously helical
Lipidation
843 – 843
S-palmitoyl cysteine
Helix
854 – 858
Literature citations
Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro-854-->Leu.
Bruce L.J.; Anstee D.J.; Spring F.A.; Tanner M.J.;
J. Biol. Chem. 269:16155-16158(1994)
Cited for: VARIANTS BLOOD GROUP DI(A)/MEMPHIS-II GLU-56 AND LEU-854;
Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
Yawata Y.; Kanzaki A.; Yawata A.; Doerfler W.; Oezcan R.; Eber S.W.;
Int. J. Hematol. 71:118-135(2000)
Cited for: VARIANTS SPH4 ARG-130; ARG-455; ARG-714; TRP-760; GLN-760; HIS-808; ARG-837 AND MET-837; VARIANTS ALA-38; GLU-56; ASP-72 AND LEU-854;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.